Tenofovir treatment of primary osteoblasts alters gene expression profiles: Implications for bone mineral density loss-Reference-Cited by-同舟云学术

Tenofovir treatment of primary osteoblasts alters gene expression profiles: Implications for bone mineral density loss

Published:2010-03 Issue:1 Volume:394 Page:48-53
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Grigsby Iwen F.,Pham Lan,Mansky Louis M.,Gopalakrishnan Raj,Carlson Ann E.,Mansky Kim C.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. Bone mineral content is lower in prepubertal HIV-infected children;Arpadi;J. Acquir. Immune Defic. Syndr.,2002

2. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy;Tebas;AIDS,2000

3. Adverse effects of antiretroviral therapy: focus on bone density;Vigano;Expert Opin. Drug Saf.,2004

4. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy;Madeddu;Q. J. Nucl. Med. Mol. Imaging,2004

5. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial;Gallant;JAMA,2004

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir induced Fanconi syndrome in a middle age African female from Kenya, East Africa: Case report and brief literature review;Clinical Case Reports;2024-05-24

2. The anti-HIV drug abacavir stimulates β-catenin activity in osteoblast lineage cells;JBMR Plus;2024-03-19

3. Effects of Tenofovir Disoproxil Fumarate on Bone Quality beyond Bone Density—A Scoping Review of the Literature;Pharmaceuticals;2024-01-23

4. The effect of daily oral PrEP use during pregnancy on bone mineral density among adolescent girls and young women in Uganda;Frontiers in Reproductive Health;2024-01-08

5. Application of Tenofovir Alafenamide Fumarate in Patients with Chronic Hepatitis B;Advances in Clinical Medicine;2024